Acadian Asset Management’s Carisma Therapeutics CARM Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-29,665	Closed	-$361K	–	1755
2022 Q4	$361K	Buy	29,665 +23,196	+359%	+$282K	﹤0.01%	1131
2022 Q3	$54K	Buy	+6,469	New	+$54K	﹤0.01%	1487
2021 Q2	–	Sell	-7,595	Closed	-$396K	–	2014
2021 Q1	$396K	Buy	+7,595	New	+$396K	﹤0.01%	1274